Abstract
Carrier-assist drug delivery systems (DDSs) have been developed to improve the present problems of the cancer chemotherapies. In the developed several types of DDS carriers, lipid nanoparticles (LNPs) are the most widely used for the cancer chemotherapy. Although LNPs have high biocompatibility and good circulation time in blood, precise size control of LNPs in the size range of 20–100nm is required for the cancer therapy applications. Microfluidic devices will be key apparatus to achieve the size-controlled LNP synthesis. A microfluidic device with micromixer structures also plays important role for the LNP production, because it enables rapid mixing of lipid solution and aqueous solution for precise LNP size control. This chapter provides the microfluidic-based LNP production methods from the device fabrication to DDS applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
